Search research articles
Contact Us
Filters
Showing results (11-20 of 143) with videos related to
Page
of 15
Sort By:
Breast Cancer Research : BCR
|
June 16, 2011
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition
Naoko Takebe, Ronald Q Warren, S Percy Ivy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2016
Reply to V. Launay-Vacher, T. Shimokata et al, and C. Porta et al
Jan H Beumer, Hussein Tawbi, S Percy Ivy
Cancer Prevention Research (Philadelphia, Pa.)
|
September 23, 2010
Molecular conversations and the development of the hair follicle and basal cell carcinoma
Pamela Jo Harris, Naoko Takebe, S Percy Ivy
Oncology (Williston Park, N.Y.)
|
January 22, 2016
Challenges and Opportunities for Immunotherapies in Gynecologic Cancers
Jung-min Lee, S Percy Ivy, Elise C Kohn
Trends in Cancer
|
July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality
S Percy Ivy, Johann de Bono, Elise C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2017
The <i>HRD</i> Decision<i>-</i>Which PARP Inhibitor to Use for Whom and When
Elise C Kohn, Jung-Min Lee, S Percy Ivy
Nature Reviews. Clinical Oncology
|
September 9, 2009
An overview of small-molecule inhibitors of VEGFR signaling
S Percy Ivy, Jeannette Y Wick, Bennett M Kaufman
Nature Reviews. Clinical Oncology
|
December 15, 2010
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Naoko Takebe, Pamela J Harris, Ronald Q Warren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee
S Percy Ivy, Lillian L Siu, Elizabeth Garrett-Mayer, et al.
Expert Opinion on Investigational Drugs
|
August 27, 2019
Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints
S Percy Ivy, Charles A Kunos, Fernanda I Arnaldez, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 143) with videos related to
Sort By:
Page
of 15
Breast Cancer Research : BCR
|
June 16, 2011
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition
Naoko Takebe, Ronald Q Warren, S Percy Ivy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2016
Reply to V. Launay-Vacher, T. Shimokata et al, and C. Porta et al
Jan H Beumer, Hussein Tawbi, S Percy Ivy
Cancer Prevention Research (Philadelphia, Pa.)
|
September 23, 2010
Molecular conversations and the development of the hair follicle and basal cell carcinoma
Pamela Jo Harris, Naoko Takebe, S Percy Ivy
Oncology (Williston Park, N.Y.)
|
January 22, 2016
Challenges and Opportunities for Immunotherapies in Gynecologic Cancers
Jung-min Lee, S Percy Ivy, Elise C Kohn
Trends in Cancer
|
July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality
S Percy Ivy, Johann de Bono, Elise C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2017
The <i>HRD</i> Decision<i>-</i>Which PARP Inhibitor to Use for Whom and When
Elise C Kohn, Jung-Min Lee, S Percy Ivy
Nature Reviews. Clinical Oncology
|
September 9, 2009
An overview of small-molecule inhibitors of VEGFR signaling
S Percy Ivy, Jeannette Y Wick, Bennett M Kaufman
Nature Reviews. Clinical Oncology
|
December 15, 2010
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Naoko Takebe, Pamela J Harris, Ronald Q Warren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee
S Percy Ivy, Lillian L Siu, Elizabeth Garrett-Mayer, et al.
Expert Opinion on Investigational Drugs
|
August 27, 2019
Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints
S Percy Ivy, Charles A Kunos, Fernanda I Arnaldez, et al.
Page
of 15